9,541 Shares in Fresenius Medical Care AG (NYSE:FMS) Acquired by Dorsey & Whitney Trust CO LLC

Dorsey & Whitney Trust CO LLC purchased a new position in Fresenius Medical Care AG (NYSE:FMS) during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor purchased 9,541 shares of the company’s stock, valued at approximately $216,000.

Other institutional investors and hedge funds have also modified their holdings of the company. Callan Family Office LLC acquired a new stake in shares of Fresenius Medical Care in the 4th quarter worth approximately $502,000. Callan Capital LLC acquired a new stake in shares of Fresenius Medical Care in the 4th quarter worth approximately $297,000. Sanctuary Advisors LLC acquired a new stake in shares of Fresenius Medical Care in the 4th quarter worth approximately $983,000. ABC Arbitrage SA acquired a new stake in shares of Fresenius Medical Care in the 4th quarter worth approximately $4,215,000. Finally, Verition Fund Management LLC acquired a new stake in shares of Fresenius Medical Care in the 3rd quarter worth approximately $237,000. Institutional investors and hedge funds own 8.37% of the company’s stock.

Analysts Set New Price Targets

FMS has been the topic of a number of research reports. StockNews.com upgraded Fresenius Medical Care from a “hold” rating to a “strong-buy” rating in a report on Wednesday, February 5th. Truist Financial upped their target price on Fresenius Medical Care from $23.00 to $25.00 and gave the company a “hold” rating in a research note on Monday, January 6th. Finally, Bank of America raised Fresenius Medical Care from an “underperform” rating to a “neutral” rating in a research note on Monday, December 2nd.

Fresenius Medical Care Price Performance

FMS stock opened at $24.37 on Wednesday. Fresenius Medical Care AG has a 1 year low of $17.93 and a 1 year high of $25.25. The company has a debt-to-equity ratio of 0.42, a quick ratio of 1.02 and a current ratio of 1.37. The stock’s 50 day moving average price is $23.58 and its 200 day moving average price is $22.12. The firm has a market cap of $14.30 billion, a P/E ratio of 20.14, a PEG ratio of 0.76 and a beta of 0.99.

Fresenius Medical Care Profile

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.